Trump’s OGE Form 278 lists multiple LLCs and real‑estate holdings for 2018Time: 07/31/18 03:54:26 AM (554727266)
Case Filed-17867House OversightFWD: FDA approves expensive cholesterol‑lowering drug (Praluent) – email from Sultan Bin Sulayern to Jeffrey Epstein
November 11, 20251p1 persons
Case File
d-17867House OversightFWD: FDA approves expensive cholesterol‑lowering drug (Praluent) – email from Sultan Bin Sulayern to Jeffrey Epstein
Other
The passage is a forwarded Forbes article about FDA approval of a pricey drug, with no concrete allegations, financial transactions, or wrongdoing. It merely shows a personal email chain linking a Sau Email from Sultan Bin Sulayern to Jeffrey Epstein forwards a Forbes story about Praluent. No mention of any financial deal, lobbying, or illicit activity related to the drug. The only notable connect
Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #025888
Pages
1
Persons
1
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.